Literature DB >> 31112523

High multiplicity infection following transplantation of hepatitis C virus-positive organs.

Muhammad N Zahid, Shuyi Wang, Gerald H Learn, Peter L Abt, Emily A Blumberg, Peter P Reese, David S Goldberg, George M Shaw, Katharine J Bar.   

Abstract

Highly effective direct-acting antivirals against Hepatitis C virus (HCV) have created an opportunity to transplant organs from HCV-positive individuals into HCV-negative recipients, since de novo infection can be routinely cured. As this procedure is performed more widely, it becomes increasingly important to understand the biological underpinnings of virus transmission, especially the multiplicity of infection. Here, we used single genome sequencing of plasma virus in four genotype 1a HCV-positive organ donors and their seven organ recipients to assess the genetic bottleneck associated with HCV transmission following renal and cardiac transplantation. In all recipients, de novo infection was established by multiple genetically distinct viruses that reflect the full phylogenetic spectrum of replication-competent virus circulating in donor plasma. This was true in renal and cardiac transplantation and in recipients with peak viral loads ranging between 2.9 and 6.6 log10 IU/mL. The permissive transmission process characterized here contrasts sharply with sexual or injection-related transmission, which occurs less frequently per exposure and is generally associated with a stringent genetic bottleneck. These findings highlight the effectiveness of current anti-HCV regimens, while raising caution regarding the substantially higher multiplicity of infection seen in organ transplantation-associated HCV acquisition.

Entities:  

Keywords:  Hepatitis; Organ transplantation; Transplantation; Virology

Mesh:

Year:  2019        PMID: 31112523      PMCID: PMC6668813          DOI: 10.1172/JCI127203

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Molecular Identification of Transmitted/Founder Hepatitis C Viruses and Their Progeny by Single Genome Sequencing.

Authors:  Hui Li; Muhammad N Zahid; Shuyi Wang; George M Shaw
Journal:  Methods Mol Biol       Date:  2019

2.  Transplanting HCV-Infected Kidneys into Uninfected Recipients.

Authors:  David S Goldberg; Peter L Abt; Peter P Reese
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

3.  Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies.

Authors:  Kelly H Schlendorf; Sandip Zalawadiya; Ashish S Shah; Mark Wigger; Chan Y Chung; Sarah Smith; Matthew Danter; Chun W Choi; Mary E Keebler; D Marshall Brinkley; Suzanne Brown Sacks; Henry Ooi; Roman Perri; Joseph A Awad; Samuel Lewis; Rachel Hayes; Heather O'Dell; Callie Darragh; Alicia Carver; Cori Edmonds; Shelley Ruzevich-Scholl; JoAnn Lindenfeld
Journal:  J Heart Lung Transplant       Date:  2018-01-31       Impact factor: 10.247

4.  Characterization of hepatitis C virus deletion mutants circulating in chronically infected patients.

Authors:  Suwanna Noppornpanth; Saskia L Smits; Truong Xuan Lien; Yong Poovorawan; Albert D M E Osterhaus; Bart L Haagmans
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

5.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.

Authors:  Brandon F Keele; Elena E Giorgi; Jesus F Salazar-Gonzalez; Julie M Decker; Kimmy T Pham; Maria G Salazar; Chuanxi Sun; Truman Grayson; Shuyi Wang; Hui Li; Xiping Wei; Chunlai Jiang; Jennifer L Kirchherr; Feng Gao; Jeffery A Anderson; Li-Hua Ping; Ronald Swanstrom; Georgia D Tomaras; William A Blattner; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Myron S Cohen; David C Montefiori; Barton F Haynes; Brian Gaschen; Gayathri S Athreya; Ha Y Lee; Natasha Wood; Cathal Seoighe; Alan S Perelson; Tanmoy Bhattacharya; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-19       Impact factor: 11.205

6.  Naturally occurring hepatitis C virus subgenomic deletion mutants replicate efficiently in Huh-7 cells and are trans-packaged in vitro to generate infectious defective particles.

Authors:  Laura Pacini; Rita Graziani; Linda Bartholomew; Raffaele De Francesco; Giacomo Paonessa
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

7.  Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.

Authors:  Christine M Durand; Mary G Bowring; Diane M Brown; Michael A Chattergoon; Guido Massaccesi; Nichole Bair; Russell Wesson; Ashraf Reyad; Fizza F Naqvi; Darin Ostrander; Jeremy Sugarman; Dorry L Segev; Mark Sulkowski; Niraj M Desai
Journal:  Ann Intern Med       Date:  2018-03-06       Impact factor: 51.598

8.  Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification.

Authors:  Hui Li; Mark B Stoddard; Shuyi Wang; Elena E Giorgi; Lily M Blair; Gerald H Learn; Beatrice H Hahn; Harvey J Alter; Michael P Busch; Daniel S Fierer; Ruy M Ribeiro; Alan S Perelson; Tanmoy Bhattacharya; George M Shaw
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

9.  Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate.

Authors:  Ruy M Ribeiro; Hui Li; Shuyi Wang; Mark B Stoddard; Gerald H Learn; Bette T Korber; Tanmoy Bhattacharya; Jeremie Guedj; Erica H Parrish; Beatrice H Hahn; George M Shaw; Alan S Perelson
Journal:  PLoS Pathog       Date:  2012-08-23       Impact factor: 6.823

10.  Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection.

Authors:  Rowena A Bull; Fabio Luciani; Kerensa McElroy; Silvana Gaudieri; Son T Pham; Abha Chopra; Barbara Cameron; Lisa Maher; Gregory J Dore; Peter A White; Andrew R Lloyd
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

View more
  2 in total

1.  Bypassing the bottleneck: intentional hepatitis C transmission with organ transplant.

Authors:  Christine M Durand; Michael A Chattergoon
Journal:  J Clin Invest       Date:  2019-06-24       Impact factor: 14.808

Review 2.  Transplantation of Organs from Hepatitis C Virus-Positive Donors under Direct-Acting Antiviral Regimens.

Authors:  Muhammad Nauman Zahid
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.